Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Shares of Optimer Pharmaceuticals Inc. (NASDAQ:OPTR) jumped $1.85 (14%) to $14.66 on Monday after media reports surfaced that at
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury